Fresenius Medical Care AG & Co. KGaA (FMEA) - Total Liabilities

Latest as of March 2026: €17.26 Billion EUR ≈ $20.18 Billion USD

Based on the latest financial reports, Fresenius Medical Care AG & Co. KGaA (FMEA) has total liabilities worth €17.26 Billion EUR (≈ $20.18 Billion USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Fresenius Medical Care AG & Co. KGaA (FMEA) investment intensity to see how much of total assets are deployed in long-term investments.

Fresenius Medical Care AG & Co. KGaA - Total Liabilities Trend (2016–2025)

This chart illustrates how Fresenius Medical Care AG & Co. KGaA's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Fresenius Medical Care AG & Co. KGaA assets under control.

Fresenius Medical Care AG & Co. KGaA Competitors by Total Liabilities

The table below lists competitors of Fresenius Medical Care AG & Co. KGaA ranked by their total liabilities.

Company Country Total Liabilities
King Yuan Electronics Co Ltd
TW:2449
Taiwan NT$40.28 Billion
Federal Realty Investment Trust
NYSE:FRT
USA $5.44 Billion
Harmony Gold Mining Company Limited
F:HAM
Germany €62.42 Billion
Groep Brussel Lambert NV
BR:GBLB
Belgium €11.68 Billion
Konfoong Materials International Co Ltd
SHE:300666
China CN¥7.69 Billion
SG Micro Corp
SHE:300661
China CN¥1.69 Billion
The Siam Cement Public Company Limited
BK:SCC
Thailand ฿425.91 Billion
Henan Shijia Photons Technology Co Ltd
SHG:688313
China CN¥1.07 Billion

Liability Composition Analysis (2016–2025)

This chart breaks down Fresenius Medical Care AG & Co. KGaA's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See FMEA net asset quality index to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.20 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 1.30 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.55 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Fresenius Medical Care AG & Co. KGaA's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Fresenius Medical Care AG & Co. KGaA (2016–2025)

The table below shows the annual total liabilities of Fresenius Medical Care AG & Co. KGaA from 2016 to 2025.

Year Total Liabilities Change
2025-12-31 €16.72 Billion
≈ $19.55 Billion
-6.06%
2024-12-31 €17.80 Billion
≈ $20.81 Billion
-6.83%
2023-12-31 €19.10 Billion
≈ $22.33 Billion
-5.92%
2022-12-31 €20.30 Billion
≈ $23.74 Billion
-0.41%
2021-12-31 €20.39 Billion
≈ $23.84 Billion
+5.32%
2020-12-31 €19.36 Billion
≈ $22.63 Billion
-1.77%
2019-12-31 €19.71 Billion
≈ $23.04 Billion
+47.73%
2018-12-31 €13.34 Billion
≈ $15.60 Billion
+1.09%
2017-12-31 €13.20 Billion
≈ $15.43 Billion
-10.32%
2016-12-31 €14.72 Billion
≈ $17.20 Billion
--

About Fresenius Medical Care AG & Co. KGaA

F:FMEA Germany Medical Care Facilities
Market Cap
$12.43 Billion
€10.64 Billion EUR
Market Cap Rank
#2257 Global
#468 in Germany
Share Price
€19.80
Change (1 day)
+1.02%
52-Week Range
€17.70 - €23.60
All Time High
€37.68
About

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, the United States, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arr… Read more